Bio-Rad Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,590	2,583	2,567	2,671	2,802	2,923
Revenue Growth (YoY)	1.92%	0.65%	-3.92%	-4.67%	-4.12%	14.81%
Cost of Revenue	1,247	1,243	1,188	1,244	1,235	1,284
Gross Profit	1,343	1,340	1,379	1,427	1,567	1,638
Selling, General & Admin	847.9	844.3	814	841.7	827.8	877.12
Research & Development	265	275.6	295.9	247.4	256.9	260.64
Other Operating Expenses	172.8	172.8	-	-	-	-
Total Operating Expenses	1,286	1,293	1,110	1,089	1,085	1,138
Operating Income	230.4	47.2	269	337.8	482.6	500.34
Interest Expense	-49.3	-49	-48.9	-49.4	-38.1	-1.55
Other Non-Operating Income (Expense)	211.9	997.3	-2,563	-1,139	-5,149	4,950
Total Non-Operating Income (Expense)	162.6	948.3	-2,612	-1,188	-5,187	4,949
Pretax Income	222.7	995.5	-2,343	-850.1	-4,704	5,449
Provision for Income Taxes	53.5	235.6	-498.3	-212.8	-1,077	1,195
Net Income	168.8	759.9	-1,844	-637.3	-3,628	4,254
Net Income to Common	168.8	759.9	-1,844	-637.3	-3,628	4,254
Net Income Growth	-	-	-	-	-	11.54%
Shares Outstanding (Basic)	27	27	28	29	30	30
Shares Outstanding (Diluted)	27	27	28	29	30	30
Shares Change (YoY)	-3.75%	-3.31%	-3.41%	-1.93%	-1.40%	0.16%
EPS (Basic)	6.11	27.87	-65.36	-21.82	-121.79	142.61
EPS (Diluted)	6.07	27.85	-65.36	-21.82	-121.79	140.83
EPS Growth	-	-	-	-	-	11.35%
Shares Outstanding	26.83	26.99	28.01	28.52	29.6	29.93
Free Cash Flow	357.2	374.6	289.6	218.2	81.6	535.72
Free Cash Flow Growth	-4.64%	29.35%	32.72%	167.40%	-84.77%	12.45%
Free Cash Flow Per Share	13.21	13.73	10.26	7.47	2.74	17.73
Gross Margin	51.87%	51.87%	53.73%	53.42%	55.93%	56.05%
Operating Margin	8.90%	1.83%	10.48%	12.65%	17.22%	17.12%
Profit Margin	6.52%	29.42%	-71.86%	-23.86%	-129.45%	145.57%
FCF Margin	13.79%	14.50%	11.28%	8.17%	2.91%	18.33%
EBITDA	271.3	212.6	420.6	483.7	482.6	500.34
EBITDA Margin	10.48%	8.23%	16.39%	18.11%	17.22%	17.12%
EBIT	230.4	47.2	269	337.8	482.6	500.34
EBIT Margin	8.90%	1.83%	10.48%	12.65%	17.22%	17.12%
Effective Tax Rate	24.02%	23.67%	21.27%	25.03%	22.89%	21.93%

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q